Home
Conditions
Diabetes Mellitus Type 2

Clinical trial condition

Diabetes Mellitus Type 2

Explore clinical trials studying Diabetes Mellitus Type 2. Study availability and eligibility vary by location and protocol.

255 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus Type 2 trial results

Completed

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

NCT00961909

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Anaheim, California, United States

Chula Vista, California, United States

Fort Myers, Florida, United States

Miramar, Florida, United States

View Trial Details

Completed

A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy

NCT01871415

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Shanghai, China

Shenyang, China

Shiyan, China

Suzhou, China

View Trial Details

Completed

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

NCT00460941

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Harrisburg, Arkansas, United States

Hot Springs, Arkansas, United States

Jonesboro, Arkansas, United States

National City, California, United States

View all 29 locations

View Trial Details

Completed

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease

NCT01680978

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Oxford, United Kingdom

View Trial Details

Completed

A Study of Taspoglutide in Type 2 Diabetic Patients

NCT00811460

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Neuss, Germany

View Trial Details

Completed

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

NCT00266240

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Tucson, Arizona, United States

Pine Bluff, Arkansas, United States

Chula Vista, California, United States

Spring Valley, California, United States

View all 44 locations

View Trial Details

Completed

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

NCT00388986

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Cypress, California, United States

Honolulu, Hawaii, United States

Buffalo, New York, United States

San Antonio, Texas, United States

View Trial Details

Completed

A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.

NCT00517465

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Berlin, Germany

Neuss, Germany

Balatonfüred, Hungary

Budapest, Hungary

View Trial Details

Completed

A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

NCT01043029

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Camperdown, New South Wales, Australia

St Leonards, New South Wales, Australia

Brisbane, Queensland, Australia

Elizabeth Vale, South Australia, Australia

View all 80 locations

View Trial Details

Completed

A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin

NCT01729403

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
Locations: Neuss, Germany

View Trial Details

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2 trial results

Related conditions